Our Products

Canterbury Medical is advancing AI solutions to enhance disease screening and diagnosis by identifying biomarkers. This technology leverages a unique signal for various conditions, enabling non-invasive and rapid diagnosis. The focus is on improving the detection accuracy and enhancing early diagnosis and treatment outcomes​​​​.

The development of enhanced breath device technology at Canterbury Medical aims to improve the sensitivity and specificity of VOC detection. By advancing the precision of these devices, the goal is to facilitate more effective disease screening and diagnostics. This involves refining the sensor technologies and analytical algorithms to better capture and interpret the chemical markers present in exhaled breath, ultimately leading to more reliable and comprehensive diagnostic tools​​​​.

Canterbury Medical utilizes advanced AI to process images from standard eye exams to identify biomarkers for disease screening and diagnosis. This innovative approach allows for the early detection of not only eye-related diseases such as diabetic retinopathy and glaucoma but also systemic conditions like diabetes, hypertension, and Alzheimer's disease. The AI systems analyze retinal images to detect subtle changes and patterns indicative of these conditions, providing a non-invasive, quick, and efficient diagnostic method​​​​.

Canterbury Medical is leveraging the power of mobile device cameras to develop AI solutions for identifying and monitoring moles, focusing particularly on early detection of skin cancers. By using advanced image recognition and machine learning algorithms, these solutions can analyze images of moles taken with smartphone cameras to detect irregularities and changes over time, prompting users to seek medical evaluation if necessary. This approach aims to make skin cancer screening more accessible and convenient​​.

In response to the growing concern of fungal infections and their impact on food and human health security, Canterbury Medical is investigating the role of fungi through AI-driven analysis. The focus is on developing AI solutions to detect and respond to fungal infections, particularly those that contribute to anti-fungal resistance. By analyzing fungal patterns and behaviors, the AI technology aims to enhance the identification and management of fungal threats, improving health outcomes and food safety​​.

Canterbury Medical is exploring the potential of AI in identifying vulnerabilities in diseases like Ebola by focusing on specific protein strains. This research aims to understand how AI can pinpoint weaknesses in disease pathogens, which can then be applied to other diseases. The insights gained from this AI-driven analysis can lead to the development of targeted treatments and preventive measures, enhancing global health security and disease management​​.